Founded in 2010, Nuvera focuses exclusively on the rare disease and specialty therapeutics markets. The firm helps pharma and biotech firms design and enable seamless and streamlined treatment experiences.
The consulting firm's team of more than 20 employees has supported 7 of the top 10 pharma companies, as well as numerous startups and mid-sized firms.
Ashfield Engage's acquisition of Nuvera will enhance the company's patient solutions practice. The addition of Nuvera will create a strategic offering that stretches across the pharma product lifecycle, including late-phase clinical trial experience, implementation, and post-commercialization satisfaction benchmarking and service optimization.
To continue reading, become an ALM digital reader
Benefits include:
- Complimentary access to Consulting Magazine Online and digital edition
- Bi-monthly digital newsletter delivered to your inbox
- 1 free article* every 30 days to Consulting Magazine's sister publications
- Exclusive discounts on events and publications produced by ALM
Already have an account? Sign In